本網站部分功能不支援IE瀏覽器,請使用Chrome或Edge等其它瀏覽器。

QT Medical Receives CE Mark for Home-Use 12-lead ECG

QT Medical strives to make hospital grade 12-lead electrocardiograms (ECG) accessible to everyone everywhere.

PCA 500 has allowed me to streamline my patient care in my practice

PCA 500 has allowed me to streamline my patient care in my practice. I would recommend it to anyone who wants to provide better care for their cardiac patients!

QT Medical Unveils the Personal Cardiac Assistant 500

Las Vegas-- 01/11/2019 -- QT Medical announces the launch of its Personal Cardiac Assistant (PCA 500) at the world’s largest technology showcase, CES. PCA 500 is the only FDA-cleared, hospital quality 12-lead electrocardiogram (ECG) for personal use. QT Medical’s CEO Dr. Ruey-Kang Chang and his team exhibited the PCA 500 at the startup zone in Eureka Park.

QT Medical Selected as a Finalist for CONNECT’s 2018 Most Innovative New Product Awards

QT ECG is selected to be among 4 Finalists in the Life Science Research Tools and Medical Device Category

QT Medical receives the “Best Presenter Award” at the 2018 New York Venture Capital Summit

Dr Ruey-Kang Chang, CEO of QT Medical, garners praise at the Venture Capital Summit held in New York

QT Medical Receives U.S. FDA 510(k) Clearance for Home-use 12-lead ECG

QT Medical aims to bridge the gap between patients and healthcare providers using their cloud-based 12-lead ECG system to bring high quality cardiac care to homes.

QT Medical wins the People’s Choice Award in the American Telemedicine Association’s 2018 Pitch Jam

QT Medical, Inc., one of the six finalists, has won the People’s Choice Award in the American Telemedicine Association’s 2018 Pitch Jam competition taking place at the end of April 2018 in Chicago, IL, USA.

QT Medical CEO Dr. Ruey-Kang Chang Wins Digital Health Challenge Award at the Annual MedImmune California Translational Science Forum

Mountain View, California, September 26, 2017 – QT Medical, the leader in ECG technology, has announced that its CEO, Dr. Ruey-Kang Chang, has been awarded the grand prize of Digital Health Challenge - a competition held by MedImmune. The competition was part of the Digital Health Transforming Drug Development Translational Science Forum, hosted annually by MedImmune, the global biologics research and development arm of AstraZeneca.

聯絡我們

本網站使用cookie收集有關您的瀏覽信息,以提供最佳體驗。